We invite you to visit our redesigned website, which takes off this week!
You can check out the most recent edition of the Advance newsletter, learn about newly accredited organizations, see upcoming webinars, and read revised tip sheets. Also find out about our 2013 Conference in Miami!
Just go to the website to see our standards, procedures, and fee schedule.
New to our site are the logos and some case studies of accredited organizations.
Please check it out and let us know what you think.
Showing posts with label News Event. Show all posts
Showing posts with label News Event. Show all posts
Tuesday, September 25, 2012
Wednesday, September 19, 2012
AAHRPP Offers Educational Webinar
IRB Review of Research Involving Adults With Diminished Capacity to Consent
Almost every IRB deals with research involving participants with diminished capacity to consent, in projects that either directly study such populations or affect them incidentally. This webinar will describe the AAHRPP requirements for research involving participants with diminished capacity to consent, what researchers should know and plan for, and how IRBs should review and approve such research. (Elements II.4.A. and II.4.B)
The Presenters:
Leslie Katzel, M.D., Ph.D., University of Maryland School of Medicine and the Baltimore Veterans Affairs Medical Center
Susan Stayn, J.D., Stanford University
Dates and Times:
October 23, 2012, 8:00 a.m. Register for October 23 webinar
October 25, 2012, 3:30 p.m. Register for October 25 webinar
The cost for each connection is $90 for AAHRPP clients
and $130 for non-clients (including as many colleagues as you wish)
Almost every IRB deals with research involving participants with diminished capacity to consent, in projects that either directly study such populations or affect them incidentally. This webinar will describe the AAHRPP requirements for research involving participants with diminished capacity to consent, what researchers should know and plan for, and how IRBs should review and approve such research. (Elements II.4.A. and II.4.B)
The Presenters:
Leslie Katzel, M.D., Ph.D., University of Maryland School of Medicine and the Baltimore Veterans Affairs Medical Center
Susan Stayn, J.D., Stanford University
Dates and Times:
October 23, 2012, 8:00 a.m. Register for October 23 webinar
October 25, 2012, 3:30 p.m. Register for October 25 webinar
The cost for each connection is $90 for AAHRPP clients
and $130 for non-clients (including as many colleagues as you wish)
Labels:
News Event,
Webinars and Conferences
Monday, August 27, 2012
Conference in Bangalore, India: November 3-4, 2012
AAHRPP is co-organizing with Manipal Hospitals and Pfizer a conference entitled Practical Solutions to Challenges in Research Ethics.
The Manipal Hospitals are the first in India to achieve AAHRPP accreditation, and the focus of the conference is on strengthening human research protection programs, sharing solutions, and thinking about the challenges ahead. It is intended for hospitals, investigators, human subject protection professionals, and sponsors of research.
The two-day conference begins on November 3 at the Hotel Matthan in Bangalore. Please check with AAHRPP for registration information, including discounted rates for researchers and academia. For further details, please contact Sarah Kiskaddon.
The Manipal Hospitals are the first in India to achieve AAHRPP accreditation, and the focus of the conference is on strengthening human research protection programs, sharing solutions, and thinking about the challenges ahead. It is intended for hospitals, investigators, human subject protection professionals, and sponsors of research.
The two-day conference begins on November 3 at the Hotel Matthan in Bangalore. Please check with AAHRPP for registration information, including discounted rates for researchers and academia. For further details, please contact Sarah Kiskaddon.
Thursday, July 19, 2012
Network for Excellence in Neuroscience Clinical Trials—NeuroNext—Uses AAHRPP-Accredited Centralized IRB
A recent NIH initiative expands capability for exploratory (phase II) trials of treatments for neurological diseases. The National Institute for Neurological Disorders recently made awards to 25 U.S. clinical sites, a clinical coordinating center, and a data coordinating center to build a “network of excellence” to speed the translation of advances in neuroscience research into clinical practice.
One innovative feature of NeuroNext is the mandatory use of an AAHRPP-accredited central institutional review board (IRB) by participating sites. Partners Healthcare’s IRB was awarded a grant to provide central IRB services to the network.
This infrastructure, funded for at least seven years, is intended to streamline trial contracting and IRB review, and to grant access to research participants all over the country. The goal is to reduce the time it takes to complete the studies, as well as the expense of phase II clinical trials, by as much as 50 percent.
One innovative feature of NeuroNext is the mandatory use of an AAHRPP-accredited central institutional review board (IRB) by participating sites. Partners Healthcare’s IRB was awarded a grant to provide central IRB services to the network.
This infrastructure, funded for at least seven years, is intended to streamline trial contracting and IRB review, and to grant access to research participants all over the country. The goal is to reduce the time it takes to complete the studies, as well as the expense of phase II clinical trials, by as much as 50 percent.
Subscribe to:
Posts (Atom)